Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

BioAtla (BCAB) Return on Capital Employed (2021 - 2025)

BioAtla's Return on Capital Employed history spans 5 years, with the latest figure at 8.41% for Q4 2025.

  • For Q4 2025, Return on Capital Employed rose 1014.0% year-over-year to 8.41%; the TTM value through Dec 2025 reached 8.41%, up 1014.0%, while the annual FY2025 figure was 5.29%, 426.0% down from the prior year.
  • Return on Capital Employed reached 8.41% in Q4 2025 per BCAB's latest filing, up from 18.76% in the prior quarter.
  • In the past five years, Return on Capital Employed ranged from a high of 8.41% in Q4 2025 to a low of 18.76% in Q3 2025.
  • Average Return on Capital Employed over 5 years is 1.53%, with a median of 0.68% recorded in 2023.
  • The largest YoY upside for Return on Capital Employed was 1014bps in 2025 against a maximum downside of -1688bps in 2025.
  • A 5-year view of Return on Capital Employed shows it stood at 0.39% in 2021, then crashed by -50bps to 0.59% in 2022, then tumbled by -106bps to 1.21% in 2023, then crashed by -43bps to 1.73% in 2024, then soared by 587bps to 8.41% in 2025.
  • Per Business Quant, the three most recent readings for BCAB's Return on Capital Employed are 8.41% (Q4 2025), 18.76% (Q3 2025), and 3.96% (Q2 2025).